Clayton A, Thomas J, Thomas G J, Davies M, Steadman R
Institute of Nephrology, University of Wales College of Medicine, Cardiff, Wales, United Kingdom.
Kidney Int. 2001 Jun;59(6):2084-94. doi: 10.1046/j.1523-1755.2001.00723.x.
While the progression of renal disease to end stage is strongly correlated with tubulointerstitial changes, the control of the fibrotic process within the interstitium is poorly understood. Basic fibroblast growth factor (FGF-2) has been implicated as a major growth factor involved in fibroblast activation and extracellular matrix synthesis. Furthermore, in many cells, the activity of FGF-2 is controlled by a low-affinity but high-capacity interaction with heparan sulfate (HS) proteoglycans (PGs), such as members of the syndecan family. These molecules are likely to be central to the control of interstitial fibrosis, but as yet, there has been no characterization of their synthesis by interstitial cells.
The expression of HSPG on the surface of NRK 49F fibroblasts was demonstrated by immunohistochemistry and by metabolic labeling with [(35)S]-sulfate. HSs were characterized by specific enzymatic digestion, size exclusion chromatography, and anion exchange chromatography. The mRNA for syndecan 1 through syndecan 4 in the fibroblasts was detected by semiquantitative reverse transcription-polymerase chain reaction. Fibroblast proliferation was measured by the MTT assay.
Immunohistochemistry and [(35)S]-sulfate-labeling demonstrated that renal fibroblasts expressed HSPGs on their surface. Furthermore, enzymatic removal of these HS (but not chondroitin sulfate) glycosaminoglycan (GAG) chains, or inhibition of GAG sulfation, abolished the proliferative response of both NRK cells and primary human cortical fibroblasts to FGF-2 but not to platelet-derived growth factor. The addition of conditioned medium, containing HS-GAG fragments, restored the proliferative response to FGF-2, confirming the specificity of the interaction. Finally, the mRNA for all four syndecans was detected in the fibroblasts, and that for syndecan 1 in particular was up-regulated by FGF-2.
The present study demonstrates that the expression of cell surface HSPG was essential for the proliferation of renal fibroblasts in response to FGF-2, and therefore may play a major role in the development and persistence of a proliferating phenotype during interstitial nephritis.
虽然肾脏疾病进展至终末期与肾小管间质改变密切相关,但对间质内纤维化过程的控制却知之甚少。碱性成纤维细胞生长因子(FGF-2)被认为是参与成纤维细胞活化和细胞外基质合成的主要生长因子。此外,在许多细胞中,FGF-2的活性受其与硫酸乙酰肝素(HS)蛋白聚糖(PG)(如syndecan家族成员)的低亲和力但高容量相互作用的控制。这些分子可能是控制间质纤维化的关键,但迄今为止,尚未对间质细胞合成这些分子进行表征。
通过免疫组织化学和用[(35)S]-硫酸盐进行代谢标记来证明NRK 49F成纤维细胞表面HSPG的表达。通过特异性酶消化、尺寸排阻色谱和阴离子交换色谱对HS进行表征。通过半定量逆转录-聚合酶链反应检测成纤维细胞中syndecan 1至syndecan 4的mRNA。通过MTT法测量成纤维细胞增殖。
免疫组织化学和[(35)S]-硫酸盐标记表明肾成纤维细胞在其表面表达HSPG。此外,酶促去除这些HS(而非硫酸软骨素)糖胺聚糖(GAG)链,或抑制GAG硫酸化,消除了NRK细胞和原代人皮质成纤维细胞对FGF-2的增殖反应,但对血小板衍生生长因子无此作用。添加含有HS-GAG片段的条件培养基可恢复对FGF-2的增殖反应,证实了相互作用的特异性。最后,在成纤维细胞中检测到所有四种syndecan的mRNA,特别是syndecan 1的mRNA被FGF-2上调。
本研究表明细胞表面HSPG的表达对于肾成纤维细胞对FGF-2的增殖反应至关重要,因此可能在间质性肾炎期间增殖表型的发展和持续中起主要作用。